Drug Discovery

#Automation #Drug discovery #SLAS2023 #Sustainability

Highlights from SLAS2023: Day Two

Day two of SLAS2023 had a range of exciting announcements from industry providers. Here is a selection of some the highlights that the show had to offer. ThinkCyte launches new sorting platform Biotechnology company ThinkCyte launched its new sorting platform at the show. VisionSort is powered by the company’s… Read More

#News

Rare Disease Day
#Drug discovery #Rare cancers #Rare disease #Rare Disease Day

Five 2023 breakthroughs in drug discovery for rare diseases

Rare diseases are often overlooked for funding and research, but with various incentives and priority review programmes now in place, many companies are beginning to explore these unusual but often devastating conditions. This Rare Disease Day we provide an overview of the progress that has been made in… Read More

#News #Trending News

Rare disease
#Clinical development #Drug development #Drug discovery #Rare disease #Rare Disease Day

What is the biggest barrier to rare disease drug development?

Dr Asma Patel, Vice President of Integrated Services for Early Development at Quotient Sciences, reflects on the biggest barriers to rare disease drug development and how companies can overcome these. Despite improvements in regulatory support and commercial rewards, difficulties remain for drug developers in bringing rare disease drugs… Read More

#Exclusive Content #Opinion

San Diego Conference Centre
#Automation #Biopharma #Drug discovery #SLAS2023

Highlights from SLAS2023: Day One

The first full day of SLAS2023 offered plenty for visitors to see and learn from. Here are some of the biggest launches that were on offer throughout day one of the show. PerkinElmer targets screening methods End-to-end solutions provider PerkinElmer launched two new products at the show targeting both high… Read More

#News

#Covid-19 #Drug development #Drug discovery #HIV #Immunity #Immunology / Virology & Vaccines #Vaccines

New episode of the DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Our news highlights this week focus on research into vaccines, with… Read More

#News

#Covid-19 #Drug development #Drug discovery #HIV #Immunity #Immunology / Virology & Vaccines #Vaccines

This week in drug discovery (20-24 February)

News round-up for 20-24 February by DDW Digital Content Editor Diana Spencer.  Our news highlights this week focus on research into vaccines, with good news for the treatment or prevention of various challenging conditions, including Covid-19, Strep A and HIV. Particularly interesting is the announcement that a new class… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Webinar: Choose the right drug candidates from your hit list

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News

DNA biopharma image
#Biopharmaceutical #Biotechnology #Drug discovery #Sustainability

Future trends: biopharma to outpace small molecule drug development  

Gary Connors, Partner at business consulting company Oliver Wight EAME looks at some of the most important factors that will affect the pharmaceutical industry going forward.   We advise all our clients to make assumptions and think about scenarios that could affect their business at least five years in… Read More

#Exclusive Content

#Business #Drug development #Drug discovery #Marketing #Pharmaceuticals #Regulatory

The three key stages to a successful specialty drug launch

Listen to this article on the DDW Podcast: Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market.  In today’s competitive environment, a winning, fail-safe drug launch strategy is more important than ever, especially… Read More

#Exclusive Content #Regulatory

#AI / data analytics / healthtech / informatics #Automation / robotics #Ginkgo Bioworks #Lab automation #Lab technology #SLAS2023 #Synthetic biology

Connecting lab automation to decision-making

Ashwin Pillai is Test Engineer 3 in HTS & Assay Development at Ginkgo Bioworks, a company whose mission is to make biology easier to engineer. Ahead of his presentation in the Automation Technologies Track at SLAS2023, Pillai shares insight on data and how we can connect lab automation to decisions. Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #SLAS2023 #Therapeutics

Podcast: Acquiring deeper insights and acceleration with AI

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode two, Acquiring deeper insights and acceleration with AI. At IBM… Read More

#News

#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #Labforward #Podcast #Sitting Down With podcast

The integration puzzle: Open ecosystem can unlock the potential of lab data

The latest sponsored DDW Sitting Down With podcast features Simon Bungers, CEO, Labforward and explains why the promises of big data, AI and ML are only illusions if the integration puzzle isn’t solved. Among the topics Lu Rahman, Publishing Director, DDW discusses with Bungers are connectivity and interoperability in the… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Lab automation #Lab technology #Labforward #Sitting Down With podcast

New podcast: Unlock the potential of lab data

The latest sponsored DDW Sitting Down With podcast features Simon Bungers, CEO, Labforward and explains why the promises of big data, AI and ML are only illusions if the integration puzzle isn’t solved. Among the topics Lu Rahman, Publishing Director, DDW discusses with Bungers are connectivity and interoperability in the… Read More

#News

#Biotechnology #Drug discovery #Events #Innovation #SLAS2023

DDW launches event podcast series for SLAS2023

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March), DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is episode one, A Welcome to SLAS 2023,… Read More

#News

#AI / data analytics / healthtech / informatics #Cancer research #Collaboration #Drug development #Drug discovery #Oncology #Partnership

This week in drug discovery (13-17 February)

News round-up for 13-17 February by DDW Digital Content Editor Diana Spencer.  The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of… Read More

#News

#Appointment #Big pharma #Drug discovery #Life sciences #New appointment #Pharmaceutical industry

February’s key industry appointments

There have been a number of significant appointments in the drug discovery sector over the last month. So who are the latest movers and shakers?  Amy Berrington and Montserrat Garcia-Closas, Institute of Cancer Research: Professors Amy Berrington and Montserrat Garcia-Closas have been appointed as Team Leaders at… Read More

#News